Molecule Details
| InChIKey | IQIKXZMPPBEWAD-CQSZACIVSA-N |
|---|---|
| Compound Name | Suvecaltamide |
| Canonical SMILES | CC(C)c1ccc(CC(=O)N[C@H](C)c2ccc(OCC(F)(F)F)cn2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.61 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB19139 |
|---|---|
| Drug Name | Suvecaltamide |
| CAS Number | 953778-58-0 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Suvecaltamide is under investigation in clinical trial NCT05122650 (A Study to Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)). |
Cross-references: BindingDB: 50192668 CHEMBL1684950 ChemSpider: 26388955